Drug Review Results Openly Disclosed by KFDA

Published: 2004-12-01 06:58:00

Updated: 2004-12-01 06:58:00

A recent announcement by the KFDA indicates that it will openly communicate the completed drug review results generated from the approval procedures via its online website, www.kfda.go.kr.

The areas of disclosure will generally include (a) abstract of review, (b) notes for changes/improvemen...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK